ASTELLAS PHARMA UNSP.ADR Financial Flexibility Index
ASTELLAS PHARMA UNSP.ADR financial flexibility index. ASTELLAS PHARMA UNSP.ADR (YPHA) has a Financial Flexibility Index of 0.14x as of March 2025. Free cash flow of €251.84 Billion (operating CF €194.51 Billion minus capex €57.33 Billion) represents 0% of total liabilities (€1.83 Trillion). See ASTELLAS PHARMA UNSP.ADR (YPHA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ASTELLAS PHARMA UNSP.ADR (2022–2025)
Financial flexibility index of ASTELLAS PHARMA UNSP.ADR from 2022 to 2025. Historical Financial Flexibility Index trend for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Check YPHA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
ASTELLAS PHARMA UNSP.ADR Financial Flexibility Index by Year (2022–2025)
ASTELLAS PHARMA UNSP.ADR financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for ASTELLAS PHARMA UNSP.ADR. For the full cash flow conversion analysis, see ASTELLAS PHARMA UNSP.ADR operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | €251.84 Billion | €194.51 Billion | €1.83 Trillion | ▲ +6.7% |
| 2024 | 0.13x | €254.97 Billion | €172.47 Billion | €1.97 Trillion | ▼ -70.6% |
| 2023 | 0.44x | €416.31 Billion | €327.77 Billion | €948.56 Billion | ▲ +14.6% |
| 2022 | 0.38x | €333.89 Billion | €257.44 Billion | €872.09 Billion | — |